ArticleBiomedicines2022

Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study.

Alfredo Papa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.